checkAd
    Startseite > Aktien > Vir Biotechnology > Nachrichten
    Vir Biotechnology Aktie
    9,5600
     
    USD
    +0,21 %
    +0,0200 USD
    Letzter Kurs 09.05.24 Nasdaq
    9,5500
     
    USD
    400 STK
    Geldkurs 09.05.24
    9,5600
     
    USD
    2.500 STK
    Briefkurs 09.05.24
    ISIN: US92764N1028 · WKN: A2PS0P · SYM: VIR · USA

    Neueste Nachrichten

    Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
    02.05.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
    30.04.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
    18.04.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
    11.04.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
    05.03.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
    23.02.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
    22.02.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
    20.02.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
    01.02.24 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
    13.12.23 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
    06.12.23 · Business Wire (engl.) · Vir Biotechnology
    Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting 2023
    13.11.23 · Business Wire (engl.) · Vir Biotechnology